Compare LUCY & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUCY | ACON |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 7.4M |
| IPO Year | 2021 | 2022 |
| Metric | LUCY | ACON |
|---|---|---|
| Price | $0.72 | $2.28 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 215.0K | 41.1K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 63.39 | ★ 99.82 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,661,669.00 | $75,730.00 |
| Revenue This Year | $175.92 | $87.22 |
| Revenue Next Year | $205.56 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 62.65 | ★ 65.62 |
| 52 Week Low | $0.65 | $1.95 |
| 52 Week High | $2.24 | $12.03 |
| Indicator | LUCY | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 44.94 | 39.01 |
| Support Level | $0.66 | $1.95 |
| Resistance Level | $1.17 | $3.54 |
| Average True Range (ATR) | 0.06 | 0.17 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 50.72 | 58.93 |
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.